scholarly journals Monitoring drug safety: is the Yellow Card Scheme struggling?

Prescriber ◽  
2019 ◽  
Vol 30 (9) ◽  
pp. 32-34
Author(s):  
Steve Chaplin
Keyword(s):  
Drug Safety ◽  
Yellow Card ◽  
Yellow Card Scheme ◽  
Monitoring Drug

Monitoring Drug Safety in Rheumatoid Arthritis Prevention Trials

2019 ◽  
Vol 41 (7) ◽  
pp. 1366-1375 ◽  
Author(s):  
Martha R. Neagu ◽  
Michael A. Weinreich ◽  
Thao T. Doan ◽  
Barbara A. Hendrickson
Keyword(s):  
Rheumatoid Arthritis ◽  
Drug Safety ◽  
Monitoring Drug ◽  
Prevention Trials

UK's MHRA encourages Yellow Card Scheme reporting

2018 ◽  
Vol 1701 (1) ◽  
pp. 8-8
Keyword(s):  
Yellow Card ◽  
Yellow Card Scheme

Attitudes of hospital pharmacists to adverse drug reactions and the “yellow card” scheme: a qualitative study

1999 ◽  
Vol 7 (4) ◽  
pp. 247-255 ◽  
Author(s):  
Christopher F. Green ◽  
David R. Mottram ◽  
Adrian M. Brown ◽  
Philip H. Rowe
Keyword(s):  
Qualitative Study ◽  
Adverse Drug Reactions ◽  
Drug Reactions ◽  
Yellow Card ◽  
Hospital Pharmacists ◽  
Yellow Card Scheme

Understanding the Yellow Card Scheme: a short guide to incident reporting

2013 ◽  
Vol 2 (5) ◽  
pp. 232-235
Author(s):  
Rachel Goddard
Keyword(s):  
Incident Reporting ◽  
Yellow Card ◽  
Yellow Card Scheme

Extension of UK's yellow card scheme proposed

1996 ◽  
Vol &NA; (630) ◽  
pp. 2
Author(s):  
&NA;
Keyword(s):  
Yellow Card ◽  
Yellow Card Scheme

Monitoring drug safety with registries: useful components of postmarketing pharmacovigilance systems

2012 ◽  
Vol 65 (2) ◽  
pp. 121-125 ◽  
Author(s):  
Cameron D. Willis ◽  
John J. McNeil ◽  
Peter A. Cameron ◽  
Louise E. Phillips
Keyword(s):  
Drug Safety ◽  
Monitoring Drug ◽  
Useful Components

Adverse drug reactions in children: reports to the UK yellow card scheme 2000-2009

2011 ◽  
Vol 96 (Supplement 1) ◽  
pp. A57-A57
Author(s):  
D. B. Hawcutt ◽  
P. Mainie ◽  
R. Appleton ◽  
R. Smyth ◽  
M. Pirmohamed
Keyword(s):  
Adverse Drug Reactions ◽  
Drug Reactions ◽  
Yellow Card ◽  
Yellow Card Scheme ◽  
The Uk

scholarly journals P015 Yellow cards are still not on everyone’s to do list

2019 ◽  
Vol 104 (7) ◽  
pp. e2.18-e2
Author(s):  
Emily Horan ◽  
David Tuthill
Keyword(s):  
Adverse Drug Reaction ◽  
Drug Reaction ◽  
Healthcare Professionals ◽  
Drug Event ◽  
Yellow Card ◽  
Reporting Scheme ◽  
Know How ◽  
Learning Module ◽  
Yellow Card Scheme ◽  
E Learning

AimTo look at how the Yellow Card Scheme is used by health care professionals (HCPs) in child health.MethodsAn online SurveyMonkey questionnaire was devised to look at how healthcare professionals (HCPs) have used the Yellow Card Scheme in clinical practice. It comprised of 10 questions (9 multiple choice and 1 freestyle text). What type of healthcare professional are you? Are you aware of the Yellow Card reporting scheme? Have you ever used the Yellow Card Scheme to report an adverse drug reaction? If yes, how did you make the report? (If no, select N/A) If you haven’t ever reported a reaction, would you know how to? Have you ever completed an e learning module about the Yellow Card Scheme? Are you aware that parents can report adverse drug reactions using the Yellow Card Scheme? Have you ever been aware of an adverse drug reaction but decided not to report it? If yes, what was the reason you chose not to report it? (If no, select N/A) Can you think of any ways to make the Yellow Card Scheme more accessible to healthcare professionals? It was piloted on 5 HCPS and minor textural revisions made. The questionnaire was then undertaken via face-to-face interviews during June 2018.Results50 healthcare professionals completed the questionnaire: 16 doctors, 13 nurses, 8 pharmacists, 9 medical students, 2 nursing students and 2 pharmacy technicians. 43/50 were aware of the Yellow Card Scheme (10 undergraduates and 33 postgraduates). 18 participants had used the Yellow Card whilst 32 had not reported an adverse drug event. Out of the 32 respondents who had never reported a reaction, 13 (7 undergraduates and 6 postgraduates) said that they would not know how to report a reaction if required. Only 9 had completed an online e learning module about the Yellow Card scheme. 30 participants were aware that parents could report using the scheme. 10 participants had been aware of an adverse drug reaction but decided not to report it. The most common reason for this was being too busy. The most common suggestion on how to improve accessibility to the Yellow Card Scheme was the implementation of a mobile phone application.ConclusionMost participants were aware of the Yellow Card scheme although undergraduates less so. Many had reported, although some had chosen not to report because they were: too busy; not being concerned enough; not knowing how to; having forgotten. An app already exists, but awareness of this appears low, as it was the commonest suggestion to aid the low reporting.

Sign in / Sign up

Export Citation Format

Share Document